S&P Futures
3,918.75 +15.00 (+0.38%) Dow Futures
31,564.00 +143.00 (+0.46%) Nasdaq Futures
12,067.75 +27.25 (+0.23%) Russell 2000 Futures
1,780.40 +10.60 (+0.60%) Crude Oil
111.31 +1.74 (+1.59%) Gold
1,823.70 -1.10 (-0.06%)
BWX Technologies, Inc. (BWXT)
After hours:
Chart Events
Performance Outlook
| Previous Close | 53.17 |
| Open | 53.56 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 900 |
| Day's Range | 52.79 - 54.27 |
| 52 Week Range | 42.58 - 62.53 |
| Volume | |
| Avg. Volume | 552,314 |
| Market Cap | 4.905B |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | 17.05 |
| EPS (TTM) | 3.15 |
| Earnings Date | Aug 01, 2022 - Aug 05, 2022 |
| Forward Dividend & Yield | 0.88 (1.76%) |
| Ex-Dividend Date | May 19, 2022 |
| 1y Target Est | 63.50 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for BWXT
Related Research
- BWX Technologies, Inc.CCJ: Lowering target price to $23.00CAMECO CORP has an Investment Rating of BUY; a target price of $23.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.RatingFair ValueEconomic Moat6 days agoArgus Research
- Business Wire
BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
OTTAWA, Ontario, June 27, 2022--BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
- Benzinga
BWXT Medical, TRIUMF Agree To Manufacture High Purity Ac-225 Based Products
BWX Technologies Inc (NYSE: BWXT) subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have established a licensing and services agreement. The agreement strengthens their existing partnership for the production of medical isotopes. It enables BWXT Medical to manufacture high purity Actinium-225 (Ac-225) based products for pharmaceutical companies as it continues to build on its medical isotope production operations on the TRIUMF site. Leveraging existing infrastructure
- Business Wire
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
OTTAWA, Ontario, June 13, 2022--BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
